Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CAMP4 Therapeutics Corporation - Common Stock (NQ:CAMP)

4.690 UNCHANGED

Streaming Delayed Price Updated: 1:18 PM EDT, Mar 24, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	25,704
Open	4.590
Bid (Size)	4.690 (200)
Ask (Size)	4.800 (1,000)
Prev. Close	4.690
Today's Range	4.589 - 4.940
52wk Range	1.305 - 7.750
Shares Outstanding	20,161,073
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CAMP4 Appoints Michael MacLean to its Board of Directors

Today 7:00 EDT

Appointment enhances strategic and financial leadership as the Company advances CMP-002 toward a planned first-in-human Phase 1/2 clinical trial for SYNGAP1-related disorder

From CAMP4 Therapeutics

Via GlobeNewswire

Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit ↗

March 18, 2026

Clinical-stage biotech Dianthus Therapeutics develops antibody therapies for severe autoimmune and neuromuscular conditions.

Via The Motley Fool

Performance

YTD	-21.8%	-21.8%
1 Month	+3.8%	+3.8%
3 Month	-21.8%	-21.8%
6 Month	+70.5%	+70.5%
1 Year	-11.3%	-11.3%

More News

Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit ↗

March 18, 2026

Via The Motley Fool

CAMP4 to Participate in Upcoming Investor Conferences

March 06, 2026

From CAMP4 Therapeutics

Via GlobeNewswire

CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights

March 05, 2026

From CAMP4 Therapeutics

Via GlobeNewswire

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 20, 2026

From CAMP4 Therapeutics

Via GlobeNewswire

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026

From CAMP4 Therapeutics

Via GlobeNewswire

CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock

December 18, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 06, 2026

From CAMP4 Therapeutics

Via GlobeNewswire

CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries

December 18, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 12, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company ↗

November 29, 2025

Via The Motley Fool

5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗

November 18, 2025

Via The Motley Fool

5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out ↗

November 18, 2025

Via The Motley Fool

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 14, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights

November 06, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

3 Healthcare Companies Insiders Are Buying ↗

October 14, 2025

Via MarketBeat

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

October 01, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 10, 2025

Via Benzinga

Wednesday's after hours session: top gainers and losers ↗

September 10, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 10, 2025

Via Benzinga

CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders

September 10, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

Camp4 Reports Q2 Revenue Beats Estimates ↗

August 14, 2025

Via The Motley Fool

CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights

August 14, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

Frequently Asked Questions

Is CAMP4 Therapeutics Corporation - Common Stock publicly traded?

Yes, CAMP4 Therapeutics Corporation - Common Stock is publicly traded.

What exchange does CAMP4 Therapeutics Corporation - Common Stock trade on?

CAMP4 Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for CAMP4 Therapeutics Corporation - Common Stock?

The ticker symbol for CAMP4 Therapeutics Corporation - Common Stock is CAMP on the Nasdaq Stock Market

What is the current price of CAMP4 Therapeutics Corporation - Common Stock?

The current price of CAMP4 Therapeutics Corporation - Common Stock is 4.690

When was CAMP4 Therapeutics Corporation - Common Stock last traded?

The last trade of CAMP4 Therapeutics Corporation - Common Stock was at 03/24/26 01:18 PM ET

What is the market capitalization of CAMP4 Therapeutics Corporation - Common Stock?

The market capitalization of CAMP4 Therapeutics Corporation - Common Stock is 94.56M

How many shares of CAMP4 Therapeutics Corporation - Common Stock are outstanding?

CAMP4 Therapeutics Corporation - Common Stock has 95M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.